Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

129.45 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
49 50 Next >
5 Top Pharma Stocks of 2022 to Buy for the Long Haul
The biggest drug company blockbusters bring in billions of dollars, which is one of the reasons to consider these top Pharma stocks. 
Via InvestorPlace
2 Best Healthcare Stocks to Buy Right Now
Healthcare is a durable economic sector. 
Via The Motley Fool
Alphabet And These 2 Healthcare Stocks Insiders Are Selling
The Nasdaq Composite dropped around 80 points on the first trading day of 2023. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Beat the Dow Jones With This Unstoppable Dividend Stock
This drugmaker is accustomed to outperforming the broader market. 
Via The Motley Fool
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,500 Today
 
Via Benzinga
12 Recession-Proof Stocks
The stock market had a rough time in 2022. In this article, we are examining 12 dividend stocks whose recession-proof characteristics should enable them to keep growing their dividends in a bear market... 
Via Talk Markets
2 Top Dividend Stocks to Buy Hand Over Fist Before 2023
These stocks will bring you income -- no matter what the market is doing. 
Via The Motley Fool
Here's How Much $100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth Today
 
Via Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
These companies are safe havens during tough times, with above-average dividends. 
Via The Motley Fool
3 Stocks on Santa's Nice List to Buy Before 2023
These stocks each offer something Santa would like. 
Via The Motley Fool
2 Beaten-Down Growth Stocks Set to Rebound in 2023
It'd be a mistake to write off these two healthcare leaders. 
Via The Motley Fool
2 Exceptional Dividend Growth Stocks to Buy Now
These companies have histories of rapid payout increases and the means to continue them. 
Via The Motley Fool
1 Passive Income Stock to Buy Today, and 1 to Avoid for Now
Rising interest rates don't affect all passive income stocks equally. 
Via The Motley Fool
2022 Bargain Shopping: 2 Smart Stocks to Buy Before the New Year
These stocks look cheap -- especially considering their long-term potential. 
Via The Motley Fool
Expert Ratings for Abbott Laboratories
 
Via Benzinga
11 Analysts Have This to Say About Abbott Laboratories
 
Via Benzinga
2 Supercharged Dividend Stocks to Buy in a Bear Market
Don't let these income stocks pass you by. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Want $250 in Passive Income? Buy These 2 Dividend Kings and Wait
These companies will work hard to grow your base of passive income. 
Via The Motley Fool
2 Dividend Stocks That Could Double Your Return in 10 Years
Both companies should hurdle their patent cliff concerns. 
Via The Motley Fool
Why Abbott Laboratories Topped the Market on Tuesday
Bullish momentum behind the big pharmaceutical company was aided by a glowing new analyst note. 
Via The Motley Fool
A Career Politician Who Regularly Trades The SPY, Picked Up There 3 High Yielding ETFs Instead
Representative Robert Wittman (R-VA) is the vice-ranking member of the House Armed Services Committee and also serves on the Committee on Natural Resources. 
Via Benzinga
Reliable Passive Income: an Analysis on Dividend Kings
A Dividend King is any stock that has increased its dividend for 50+ cosecutive years, doubling that of a Dividend Aristocrat. 
Via The Motley Fool
Two Blue Chip Health Companies The Institutions Are Buying
Johnson & Johnson and Abbott Laboratories are two Dividend Kings the analysts are buying, one stock is ready to rebound and the other to lead the market. 
Via MarketBeat
2 Ultra-Reliable Dividend Stocks You Can Buy Now and Hold Forever
Here are two stocks that investors can count on to deliver increasing dividend payments for many years to come. 
Via The Motley Fool
Have $1,000? 2 Top Dividend Stocks to Buy Right Now
Dividend stocks can help investors grow their portfolios in all types of markets. 
Via The Motley Fool
2 Dividend Aristocrats to Buy for 2023
You can count on these dividend stocks to continue raising their payouts for years to come. 
Via The Motley Fool
Got $500? Where to Invest It Before 2023
These top stocks look like a deal right now. 
Via The Motley Fool
Is AbbVie Stock a Buy Now?
The pharmaceutical company prepared well as Humira approaches its patent cliff next year. 
Via The Motley Fool
Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report
 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
49 50 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.